close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar44Point70
Implied share price

Sell Overvalued by 43.3%

5% margin of safety What's this?

EV / EBITDA
Use Average
LLY
Eli Lilly & Co.
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
11.22 19.28 10.01 15.01 10.62 7.9
All amounts in millions
from last financial year
         
Implied Share Price $44.70 $111.62 $76.08 $36.72 $87.35
Market Cap 87,558 277,692 273,799 213,979 172,027
Net Debt 3,229 -14,329 6,856 560 5,684
Enterprise Value (EV) 90,787 263,363 253,266 214,539 177,711
Revenue 19,615 74,331 53,634 49,605 42,237
EBITDA 4,707 26,305 16,872 20,198 22,497
Percent 24.0 % 35.4 % 31.5 % 40.7 % 53.3 %
EBIT 3,328 22,410 12,190 14,661 15,806
Percent 17.0 % 30.1 % 22.7 % 29.6 % 37.4 %
Balance Sheet          
Total Assets 37,178 131,119 125,387 169,274 98,335
Total Liabilities 21,805 61,367 54,621 97,973 49,688
Shareholders Equity 15,373 69,752 70,766 71,301 48,647.0

Price history

Comments

No comments yet. Login to comment.